Propranolol therapy in essential hypertension.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001158:Arteries; D001219:Aspartate Aminotransferases / Q000097:blood; D001794:Blood Pressure; D001806:Blood Urea Nitrogen; D001830:Body Surface Area; D002302:Cardiac Output; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D005260:Female; D006339:Heart Rate; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011433:Propranolol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D006454:Hemoglobins; D010919:Placebos; D011433:Propranolol; D003404:Creatinine; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase